Keurig Dr Pepper (NASDAQ:KDP – Get Free Report) issued its earnings results on Tuesday. The company reported $0.58 earnings per share for the quarter, topping the consensus estimate of $0.57 by $0.01, Zacks reports. The business had revenue of $4.07 billion for the quarter, compared to analyst estimates of $4 billion. Keurig Dr Pepper had a return on equity of 10.45% and a net margin of 15.04%. The business’s quarterly revenue was up 5.2% on a year-over-year basis. During the same quarter last year, the company earned $0.55 EPS.
Keurig Dr Pepper Price Performance
Shares of NASDAQ KDP opened at $34.12 on Tuesday. The stock has a fifty day moving average price of $31.82 and a 200 day moving average price of $33.94. Keurig Dr Pepper has a 1-year low of $28.61 and a 1-year high of $38.28. The company has a debt-to-equity ratio of 0.50, a current ratio of 0.53 and a quick ratio of 0.36. The company has a market cap of $46.28 billion, a PE ratio of 20.68, a P/E/G ratio of 2.42 and a beta of 0.61.
Keurig Dr Pepper Dividend Announcement
The business also recently announced a quarterly dividend, which will be paid on Friday, April 11th. Stockholders of record on Friday, March 28th will be issued a $0.23 dividend. This represents a $0.92 dividend on an annualized basis and a dividend yield of 2.70%. The ex-dividend date is Friday, March 28th. Keurig Dr Pepper’s payout ratio is currently 55.76%.
Insider Buying and Selling at Keurig Dr Pepper
Analyst Ratings Changes
A number of analysts have weighed in on KDP shares. Barclays reissued an “overweight” rating and set a $36.00 price objective on shares of Keurig Dr Pepper in a report on Tuesday. Wells Fargo & Company reiterated an “overweight” rating on shares of Keurig Dr Pepper in a research note on Tuesday. Deutsche Bank Aktiengesellschaft raised shares of Keurig Dr Pepper from a “hold” rating to a “buy” rating and boosted their price target for the company from $37.00 to $39.00 in a research report on Thursday, December 12th. Piper Sandler started coverage on Keurig Dr Pepper in a report on Tuesday. They set a “neutral” rating and a $35.00 price objective on the stock. Finally, UBS Group reissued a “buy” rating on shares of Keurig Dr Pepper in a report on Tuesday. Six analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $37.50.
Read Our Latest Stock Analysis on Keurig Dr Pepper
About Keurig Dr Pepper
Keurig Dr Pepper Inc owns, manufactures, and distributors beverages and single serve brewing systems in the United States and internationally. It operates through three segments: U.S. Refreshment Beverages, U.S. Coffee, and International. The U.S. Refreshment Beverages segment manufactures and distributes branded concentrates, syrup, and finished beverages.
Recommended Stories
- Five stocks we like better than Keurig Dr Pepper
- What Investors Must Know About Over-the-Counter (OTC) Stocks
- February’s Top 3 Stock Upgrades: What Investors Need to Know
- 3 REITs to Buy and Hold for the Long Term
- 2 Safe-Haven Stocks Shielded From Import Tariffs
- What Are Dividend Contenders? Investing in Dividend Contenders
- Nebius Group: A Strategic Entry Point for Investors?
Receive News & Ratings for Keurig Dr Pepper Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Keurig Dr Pepper and related companies with MarketBeat.com's FREE daily email newsletter.